Moreover, a previous study showed that the cellular cytotoxicity mediated by Cetuximab, an anti-epidermal growth factor receptor monoclonal antibody, could be inhibited by HLA-E membrane expression in colon cancer cells [29]. This evidence concerns the gene EGFR and malignant colon neoplasm.